![Michael Clifford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Clifford
Director/Board Member at SynDevRx, Inc.
Michael Clifford active positions
Companies | Position | Start | End |
---|---|---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Career history of Michael Clifford
Training of Michael Clifford
Cornell University | Undergraduate Degree |
Statistics
International
United States | 3 |
Operational
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectoral
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Michael Clifford
- Experience